Invitation to the R&D Network meeting
|
Medicon Valley Alliance together with Lund Stem Cell Center, Lund University have the pleasure to invite you the Medicon Valley Alliance R&D Network meeting on 24th of November, 2021 in Lund.
Cell and gene therapies are being widely accepted as one of the most transformative innovative trends in biopharmaceuticals. Cell and gene therapies are expected to increasingly shape the medical treatment and diagnosis across a wide range of diseases. Currently there are only a few approved cell and gene therapies on the market which shows that we are still in the early stages of clinical use of these treatments. The global cell and gene therapy market was valued at $4.4 billion in 2020 and is expected to reach $15.5 billion in 2025.
Despite the clinical, and commercial, potential in cell-based therapies the whole process from concept to commercialisation is very demanding and challenging with a constant need for technological improvements, managing supply chain and manufacturing operations, regulatory concerns and enabling patient access.
In this MVA R&D Network meeting, hosted by Lund Stem Cell Center, leading researchers and industry players from the region will share their latest findings as well as discussing opportunities and challenges in developing ground-breaking cell and gene therapies.
Date: Wednesday, 24th of November, 2021 Venue: Aulan (Auditorium), Skåne University Hospital Lund, Entrégatan 7, Lund, Sweden Moderator: Johan Flygare, Associate Professor, Lund Stem Cell Center |